2021 MCGI Forum - Virtual Event

Building Bridges Through Genomic Medicine

The Maine Cancer Genomics Initiative (MCGI) is pleased to present the 4th annual MCGI Forum to bring the oncology community together in Maine and beyond. This year the Forum will focus on several key areas in the field of precision oncology, immunotherapy, neurooncology and implementation of precision oncology in clinical trial design.

For more information, contact us at mcgi@jax.org.

Please contact the event organizer for more information

Mar 26 - 27

2021

About

The Maine Cancer Genomics Initiative (MCGI), an alliance of Maine oncology providers, led by The Jackson Laboratory (JAX), is pleased to present its 4th annual MCGI Forum in a virtual format. The goal of the forum is to bring together the Maine oncology community and provide insights about the impact of precision oncology. Join us for this two-day event as we focus on access to and interpretability of precision medicine treatment options for the Maine oncology community.

We are "Building Bridges Through Genomic Medicine." During the 2021 Forum we will feature several key areas of precision oncology. The MCGI team aims to build the bridge between new translational research developments and clinical application. We have an exciting line-up of educational presentations from a number of high-profile speakers including Jedd Wolchok (Chief of Immuno-Oncology Service at MSKCC), Richard Schilsky (CMO of ASCO), and David Ashley (Director of the Brain Tumor Center at Duke Cancer Center). The event will also feature a series of roundtable discussions that participants can choose from including discussions on genomic tumor board coordination, the JAX Clinical Knowledgebase, electronic data capture systems in MCGI studies, and more. Learn about this year's planning committee.

We look forward to having you join us for this event. Download the 2021 Virtual MCGI Forum brochure.

2021 MCGI Forum - Virtual Event

About

Schedule

People

Floris Barthel, M.D.

The Jackson Laboratory

Jennifer Bourne, M.S.

The Jackson Laboratory

Erin Bradshaw

Patient Advocate Foundation

Alanna J. Church, M.Sc., M.D., FRCPC

Boston Children's Hospital

Susan Domchek, M.D.

Penn Medicine

Steven G. DuBois, M.D., M.S.

Dana-Farber Cancer Institute

Emily Edelman, M.S., CGC

The Jackson Laboratory

Leah C. Graham, Ph.D.

The Jackson Laboratory

Lory Guerrette, B.S.

The Jackson Laboratory

Petra Helbig, CCRP

The Jackson Laboratory

Ching Lau, M.D., Ph.D.

The Jackson Laboratory

Milan Radovich, Ph.D.

Indiana University School of Medicine

Lincoln D. Nadauld, M.D., Ph.D.

Intermountain Healthcare

Sara E. Patterson, Ph.D.

The Jackson Laboratory

Kate Reed, MPH, ScM, CGC

The Jackson Laboratory

Melissa Rockwood, M.S.

The Jackson Laboratory

Jens Rueter, M.D.

The Jackson Laboratory

Kunal Sanghavi, M.S., CGC

The Jackson Laboratory

Richard L. Schilsky, M.D., FACP, FSCT, FASCO

American Society of Clinical Oncology

Nikoletta Sidiropoulos, M.D.

University of Vermont Medical Center

Cara Statz, Ph.D.

The Jackson Laboratory

Roel Verhaak, Ph.D.

Christine Walko, PharmD, FCCP, BCOP

ASCO TAPUR Trial

Jedd D Wolchok, M.D., Ph.D., FASCO

Memorial Sloan Kettering Cancer Center

David M. Ashley, Ph.D., MBBS, FRACP

Duke Cancer Center